Anika Therapeutics
ANIK
$27.40
Share price
3.44%
Change (1 day)
5.38%
Change (1 year)
Categories
Anika Therapeutics (ANIK) - Cash on Hand
Cash on Hand as of December 2023 : $72.86 M
According to Anika Therapeutics's latest financial reports the company has $72.86 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Anika Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $86.32 M | -8.54% |
| 2021-12-31 | $94.38 M | -4% |
| 2020-12-31 | $98.31 M | -46.84% |
| 2019-12-31 | $0.18 B | 16.31% |
| 2018-12-31 | $0.15 B | 1.12% |
| 2017-12-31 | $0.15 B | 26.05% |
| 2016-12-31 | $0.12 B | -9.89% |
| 2015-12-31 | $0.13 B | 29.51% |
| 2014-12-31 | $0.10 B | 68.8% |
| 2013-12-31 | $63.33 M | 43.72% |
| 2012-12-31 | $44.06 M | 23.17% |
| 2011-12-31 | $35.77 M | 26.86% |
| 2010-12-31 | $28.2 M | 15.45% |
| 2009-12-31 | $24.42 M | -43.45% |
| 2008-12-31 | $43.19 M | 9.61% |
| 2007-12-31 | $39.4 M | -16.46% |
| 2006-12-31 | $47.16 M | 5.41% |
| 2005-12-31 | $44.74 M | 13.75% |
| 2004-12-31 | $39.33 M | 169.59% |
| 2003-12-31 | $14.59 M | 8.07% |
| 2002-12-31 | $13.5 M | 3.39% |
| 2001-12-31 | $13.05 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 31,364.17% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 11,319.44% | 🇮🇪 Ireland |
 Stryker Corporation SYK | $3.05 B | 4,089.83% | 🇺🇸 USA |
 STAAR Surgical STAA | $0.22 B | 202.92% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $0.33 B | 361.11% | 🇺🇸 USA |
 Hill-Rom HRC | N/A | N/A | 🇺🇸 USA |